To accomplish this, we examined pancreatic cancer tissue for LOXL2 expression via immunohistochemical (IHC) staining and evaluated the prognostic significance of LOXL2 for pancreatic cancer patients. This evidence concerns the gene LOXL2 and familial pancreatic carcinoma.